LAP2ζ binds BAF and suppresses LAP2β-mediated transcriptional repression

Sigal Shaklai, Raz Somech, Einav Nili Gal-Yam, Naamit Deshet-Unger, Sharon Moshitch-Moshkovitz, Koret Hirschberg, Ninette Amariglio, Amos J. Simon, Gideon Rechavi

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Proteins of the nuclear envelope have been implicated as participating in gene silencing. BAF, a DNA- and LEM domain-binding protein, has been suggested to link chromatin to the nuclear envelope. We have previously shown that LAP2β, a LEM-domain inner nuclear membrane protein, represses transcription through binding to HDAC3 and induction of histone H4 deacetylation. We now show that LAP2ζ, the smallest LAP2 family member, is also involved in regulation of transcription. We show that similar to other LEM-domain proteins LAP2ζ interacts with BAF. LAP2ζ-YFP and BAF co-localize in the cytoplasm, and overexpression of LAP2ζ leads to reduction of nucleoplasmic BAF. Mutations in the LAP2ζ-YFP LEM domain decrease its interaction with BAF retaining the nucleo-cytoplasmic distribution of BAF. Co-expression of LAP2β and LAP2ζ results in inhibition of LAP2β-induced gene silencing while overexpression of LAP2ζ alone leads to a small increase in transcriptional activity of various transcription factors. Our results suggest that LAP2ζ is a transcriptional regulator acting predominantly to inhibit LAP2β-mediated repression. LAP2ζ may function by decreasing availability of BAF. These findings could have implications in the study of nuclear lamina-associated diseases and BAF-dependent retroviral integration.

Original languageEnglish
Pages (from-to)267-278
Number of pages12
JournalEuropean Journal of Cell Biology
Volume87
Issue number5
DOIs
StatePublished - 21 May 2008
Externally publishedYes

Bibliographical note

Funding Information:
We thank Dr. Ilan Tsarfati (Sackler School of Medicine, Tel-Aviv University, Israel) for his helpful advice regarding the immunofluorescence studies. We thank Michal Safran and Ofer Margalit for their thorough review and helpful critics of the manuscript. G. Rechavi holds the Djerasi Chair for Oncology (Sackler School of Medicine, Tel-Aviv University). This research was supported by the Israeli Science Fund grant no. 804, the Flight Attendants Medical Research Institute (FAMRI) and Paamei Tikva Fund. Part of this work was performed in partial fulfillment of the requirements towards the Ph.D. degree of Sigal Shaklai, Sackler School of Medicine, Tel-Aviv University, Israel.

Funding

We thank Dr. Ilan Tsarfati (Sackler School of Medicine, Tel-Aviv University, Israel) for his helpful advice regarding the immunofluorescence studies. We thank Michal Safran and Ofer Margalit for their thorough review and helpful critics of the manuscript. G. Rechavi holds the Djerasi Chair for Oncology (Sackler School of Medicine, Tel-Aviv University). This research was supported by the Israeli Science Fund grant no. 804, the Flight Attendants Medical Research Institute (FAMRI) and Paamei Tikva Fund. Part of this work was performed in partial fulfillment of the requirements towards the Ph.D. degree of Sigal Shaklai, Sackler School of Medicine, Tel-Aviv University, Israel.

FundersFunder number
Israeli Science Fund804
Paamei Tikva Fund
Flight Attendant Medical Research Institute

    Keywords

    • BAF
    • Chromatin
    • Epigenetics
    • Histone modification
    • LAP2
    • LEM
    • Nuclear envelope
    • Nuclear lamina
    • PIC
    • Transcription

    Fingerprint

    Dive into the research topics of 'LAP2ζ binds BAF and suppresses LAP2β-mediated transcriptional repression'. Together they form a unique fingerprint.

    Cite this